Literature DB >> 24325452

Is there a need to redefine the diagnostic criteria for common variable immunodeficiency?

Mikko Seppänen1, Asghar Aghamohammadi, Nima Rezaei.   

Abstract

Common variable immunodeficiency (CVID) is a heterogeneous group of disorders, characterized by decreased serum levels of immunoglobulins and abnormal antibody response to protein and/or polysaccharide antigens, leading to recurrent respiratory and gastrointestinal infections, autoimmunity and malignancies. Meanwhile, several monogenic defects with CVID-like phenotype have been identified during the last decade. There is a need to reach international consensus by modifying criteria for CVID, considering various areas of uncertainty in the field.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24325452     DOI: 10.1586/1744666X.2014.870478

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  8 in total

1.  Common variable immunodeficiency (CVID): new genetic insight and unanswered questions.

Authors:  H D Ochs
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

2.  Immunoglobulin G treatment of secondary immunodeficiencies in the era of novel therapies.

Authors:  M Seppänen
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

Review 3.  Immune deficiency in chronic rhinosinusitis: screening and treatment.

Authors:  Sergio E Chiarella; Leslie C Grammer
Journal:  Expert Rev Clin Immunol       Date:  2016-08-18       Impact factor: 4.473

4.  [Immunodeficiency in chronic rhinosinusitis : An important and often underestimated cause].

Authors:  L Klimek; A Chaker; C Matthias; A Sperl; P Gevaert; P Hellings; B Wollenberg; M Koennecke; J Hagemann; J Eckrich; S Becker
Journal:  HNO       Date:  2019-09       Impact factor: 1.284

5.  Low Serum IgE Is a Sensitive and Specific Marker for Common Variable Immunodeficiency (CVID).

Authors:  Monica G Lawrence; Thamiris V Palacios-Kibler; Lisa J Workman; Alexander J Schuyler; John W Steinke; Spencer C Payne; Emily C McGowan; James Patrie; Ramsay L Fuleihan; Kathleen E Sullivan; Patricia L Lugar; Camellia L Hernandez; Douglas E Beakes; James W Verbsky; Thomas A E Platts-Mills; Charlotte Cunningham-Rundles; John M Routes; Larry Borish
Journal:  J Clin Immunol       Date:  2018-02-17       Impact factor: 8.317

Review 6.  Cytokines in common variable immunodeficiency as signs of immune dysregulation and potential therapeutic targets - a review of the current knowledge.

Authors:  Farnaz Najmi Varzaneh; Bärbel Keller; Susanne Unger; Asghar Aghamohammadi; Klaus Warnatz; Nima Rezaei
Journal:  J Clin Immunol       Date:  2014-05-15       Impact factor: 8.317

Review 7.  Comparison of diagnostic criteria for common variable immunodeficiency disorder.

Authors:  Rohan Ameratunga; Maia Brewerton; Charlotte Slade; Anthony Jordan; David Gillis; Richard Steele; Wikke Koopmans; See-Tarn Woon
Journal:  Front Immunol       Date:  2014-09-15       Impact factor: 7.561

8.  Common Variable Immunodeficiency Disorders as a Model for Assessing COVID-19 Vaccine Responses in Immunocompromised Patients.

Authors:  Rohan Ameratunga; See-Tarn Woon; Richard Steele; Klaus Lehnert; Euphemia Leung; Emily S J Edwards; Anna E S Brooks
Journal:  Front Immunol       Date:  2022-01-18       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.